Research
Research groups
Research projects
Active projects
Researchers:
Publications
203 publications
Page 13 of 21
Raimund J. Ober, Xuming Lai, Zhiping Lin & E. Sally Ward,
2004
Type: conference
Sripad Ram, E. Sally Ward & Raimund J. Ober,
2004
Type: conference
Petru Cianga, Corina Cianga, Laurette Cozma, E. Sally Ward & Eugen Carasevici,
2003, Human Immunology, 64(12), 1152-1159
Type: article
Jinchun Zhou, James E. Johnson, Victor Ghetie, Raimund J. Ober & E. Sally Ward,
2003, Journal of Molecular Biology, 332(4), 901-913
Type: article
Jason C. Huang, Mei Han, Alfredo Minguela, Silvia Pastor, Ayub Qadri & E. Sally Ward,
2003, Journal of Immunology, 171(5), 2467-2477
Type: article
E. Sally Ward, Jinchun Zhou, Victor Ghetie & Raimund J. Ober,
2003, International Immunology, 15(2), 187-195
Type: article
Todd A. Braciak, Brian Pedersen, Judy Chin, Clay Hsiao, E. Sally Ward, Igor Maricic, Alex Jahng, Frank L. Graham, Jack Gauldie, Eli E. Sercarz & Vipin Kumar,
2003, Journal of Immunology, 170(2), 765-774
Type: article
Raimund Ober, Jeffrey Caves & E. Sally Ward,
2003, Analytical Biochemistry, 312(1), 57-65
Type: article
William F. Dall' Acqua, Robert M. Woods, E. Sally Ward, Susan R. Palaszynski, Nita K. Patel, Yambasu A. Brewah, Herren Wu, Peter A. Kiener & Solomon Langermann,
2002, Journal of Immunology, 169(9), 5171-5180
Type: article
Gerburg M. Spiekermann, Patricia W. Finn, E. Sally Ward, Jennifer Dumont, Bonny L. Dickinson, Richard S. Blumberg & Wayne I. Lencer,
2002, Journal of Experimental Medicine, 196(3), 303-310
DOI: 10.1084/jem.20020400
Type: article
External roles and responsibilities
Name:
Vice President, The Antibody Society.
Role:
Participant
Year:
2020
Name:
Scientific Advisory Board of the CPRIT Therapeutic Monoclonal Antibody Lead Optimization and Development Core Facility (Program leader: Zhiqiang An, Houston, TX).
Role:
Participant
Year:
2015
Name:
Board of Directors, Antibody Society.
Role:
Participant
Year:
2019
Name:
Gordon Research Conference (‘Antibody Biology and Engineering’), Il Ciocco, Italy (discussion leader).
Role:
Speaker
Year:
2014
Name:
New York Academy of Sciences Symposium ‘Hot technologies for generating next-gen biologics’, New York, NY (invited speaker).
Role:
Speaker
Year:
2014
Name:
FASEB Science Research Conference (‘Immunoreceptors’) Steamboat Springs, CO (invited speaker).
Role:
Speaker
Year:
2014
Name:
Texas FreshAIR Annual Conference, Houston, TX (invited speaker).
Role:
Speaker
Year:
2014
Name:
MD Anderson Cancer Center, Houston, TX (invited speaker).
Role:
Speaker
Year:
2015
Name:
Antibodies: an evolving force in cancer treatment, Royal Society of Medicine, London, UK (invited speaker).
Role:
Speaker
Year:
2015
Name:
2nd Texas A&M Eng-Life Symposium, Texas A&M University, TX (Keynote address).
Role:
Speaker
Year:
2015
Name:
Distinguished Lecture Series, Department of Experimental Therapeutics, MD Anderson Cancer Centre, Houston, TX, (virtual presentation).
Role:
Speaker
Year:
2021
Name:
15th Beaune Seminar in Transplant Research, Beaune, France (invited speaker).
Role:
Speaker
Year:
2015
Name:
Gordon Research Conference (‘Drug Metabolism’), Holderness, NH (invited speaker).
Role:
Speaker
Year:
2015
Name:
3rd Antibody and Protein Therapeutics Conference, Boston, MA (Keynote address).
Role:
Speaker
Year:
2015
Name:
Fourth AACR International Conference on Frontiers in Basic Cancer Research, Phildelphia, PA (invited talk).
Role:
Speaker
Year:
2015
Name:
Peptalk Cancer Immunotherapy Conference, San Diego, CA (invited speaker).
Role:
Speaker
Year:
2016
Name:
Gordon Research Conference (‘Antibody Biology and Engineering’), Galveston, TX (Keynote address).
Role:
Speaker
Year:
2016
Name:
FASEB Science Research Conference (‘Immunoreceptors’) Snowmass, CO (invited speaker).
Role:
Speaker
Year:
2016
Name:
Amgen, Thousand Oaks, CA (invited speaker).
Role:
Speaker
Year:
2016
Name:
Congress of GFHT and CoMETH, Tours, France (invited speaker).
Role:
Speaker
Year:
2016
Name:
GTCbio’s 4th Antibody and Protein Therapeutics Conference, Boston, MA (invited speaker).
Role:
Speaker
Year:
2016
Name:
Quantitative Bioimaging (QBI) Conference, Texas A&M University, College Station, TX (invited speaker).
Role:
Speaker
Year:
2017
Name:
Selectbio’s Antibodies in Drug Discovery, Hinxton, Cambridge, UK (Keynote address).
Role:
Speaker
Year:
2017
Name:
GTCbio’s Antibody and Protein Therapeutics Conference, Baltimore, MD (keynote address).
Role:
Speaker
Year:
2017
Name:
CPRIT Therapeutic Antibody Symposium, The Brown Foundation Institute of Molecular Medicine, Houston, TX (keynote address).
Role:
Speaker
Year:
2017
Name:
17th Annual Peptalk-the Protein Science Week, San Diego, CA (invited speaker).
Role:
Speaker
Year:
2018
Name:
Human Immunology-Technology Initiative in Lupus (Lupus Research Alliance), Miami, FL (invited speaker).
Role:
Speaker
Year:
2018
Name:
Histochemical Society Annual Meeting at Experimental Biology 2018, San Diego, CA (invited speaker).
Role:
Speaker
Year:
2018
Name:
4th Annual PEGS Conference, Boston, MA (keynote address).
Role:
Speaker
Year:
2018
Name:
Selectbio’s Antibodies in Drug Discovery, Cambridge, UK (invited speaker).
Role:
Speaker
Year:
2018
Name:
FASEB Science Research Conference (‘Immunoreceptors and Immunotherapy’), Snowmass, CO (session speaker).
Role:
Speaker
Year:
2018
Name:
Bioengineering Departmental Seminar, University of Texas at Arlington, Arlington, TX (invited speaker).
Role:
Speaker
Year:
2018
Name:
CPRIT Therapeutic Antibody Core Symposium, Houston, TX (invited speaker).
Role:
Speaker
Year:
2018
Name:
Quantitative Bioimaging Conference, Rennes, France (invited speaker).
Role:
Speaker
Year:
2019
Name:
Antibody Engineering and Therapeutics Europe, Amsterdam, Netherlands (invited speaker).
Role:
Speaker
Year:
2019
Name:
Affinity 2019, Stockholm, Sweden (keynote address).
Role:
Speaker
Year:
2019
Name:
CDD-MRC Conference (‘Cancer, Immunity and Inflammation'), Cambridge, UK (invited speaker).
Role:
Speaker
Year:
2019
Name:
French Society for Immunology, Club Anticorps meeting, Paris, France (keynote address).
Role:
Speaker
Year:
2019
Name:
Annual Symposium of the Center for Targeted Therapeutics and Translational Medicine, Penn Medicine/Penn Engineering, University of Pennsylvania, Philadelphia, PA (keynote address).
Role:
Speaker
Year:
2019
Name:
Biology and Biosciences Department, University of Bath, UK (invited speaker).
Role:
Speaker
Year:
2020
Name:
Antibody Engineering and Therapeutics conference, Asia, Kyoto, Japan (keynote address).
Role:
Speaker
Year:
2020
Name:
Oxford Global, Biologics Series 2020, London, UK (invited speaker; virtual conference due to COVID-19).
Role:
Speaker
Year:
2020
Name:
16th Annual PEGS, Boston, MA (invited speaker; virtual conference due to COVID-19).
Role:
Speaker
Year:
2020
Name:
Antibody Engineering and Therapeutics Conference, Europe (invited speaker; virtual conference due to COVID-19).
Role:
Speaker
Year:
2020
Name:
11th Annual World ADC, San Diego, CA (invited speaker; virtual conference due to COVID-19).
Role:
Speaker
Year:
2020
Name:
PEGS Europe, Protein and Antibody Engineering Summit, Lisbon, Portugal (invited speaker; virtual conference due to COVID-19).
Role:
Speaker
Year:
2020
Name:
Quantitative Bioimaging Conference, Oxford, UK (invited speaker).
Role:
Speaker
Year:
2020
Name:
Scientific Advisory Board of the CPRIT Therapeutic Monoclonal Antibody Lead Optimization and Development Core Facility (Program leader: Zhiqiang An, Houston, TX).
Role:
Participant
Year:
2016
Name:
Scientific Advisory Board of the CPRIT Therapeutic Monoclonal Antibody Lead Optimization and Development Core Facility (Program leader: Zhiqiang An, Houston, TX).
Role:
Participant
Year:
2017
Name:
Scientific Advisory Board of the CPRIT Therapeutic Monoclonal Antibody Lead Optimization and Development Core Facility, (Program leader: Zhiqiang An), Houston, TX.
Role:
Participant
Year:
2018
Name:
Scientific Advisory Board of the CPRIT Therapeutic Monoclonal Antibody Lead Optimisation and Development Core Facility (Program leader: Zhiqiang An, Houston, TX).
Role:
Participant
Year:
2020
Name:
Antibody Engineering and Therapeutics conference, San Diego, CA (Keynote address).
Role:
Speaker
Year:
2018
Name:
Scientific Advisory Board for Antibody Biology and Engineering Gordon Research Conference.
Role:
Participant
Year:
2017
Name:
Scientific Advisory Board for Antibody Biology and Engineering Gordon Research Conference.
Role:
Participant
Year:
2018
Name:
Scientific Advisory Board for Antibody Biology and Engineering Gordon Research Conference.
Role:
Participant
Year:
2019
Name:
Scientific Advisory Board for Antibody Biology and Engineering Gordon Research Conference.
Role:
Participant
Year:
2020
Name:
10th Annual World ADC London, UK (invited speaker).
Role:
Speaker
Year:
2020
Name:
10th Annual World ADC London, UK (workshop speaker).
Role:
Speaker
Year:
2020
Name:
Member, Fellowship Review Committee, National Multiple Sclerosis Society. (External organisation)
Role:
Participant
Year:
2015
Name:
Member, Fellowship Review Committee, National Multiple Sclerosis Society. (External organisation)
Role:
Participant
Year:
2014
Name:
Distinguished Lecture Series,Department of Experimental Therapeutics, MD Anderson Cancer Center, Houston, TX (invited seminar: virtual presentation).
Role:
Speaker
Year:
2021
Name:
PEGS Boston Summit, Boston, MA (session chair and invited speaker; virtual conference).
Role:
Speaker
Year:
2021
Name:
Nordic POP and FinPharmaNet Meeting, Kuopio, Finland (Keynote address; virtual conference).
Role:
Speaker
Year:
2021
Name:
From laboratory to the clinic: novel approaches to unmet needs, Trinity College, Oxford (invited speaker).
Role:
Speaker
Year:
2021
Name:
B and T cell mediated autoimmune disease drug development summit (invited speaker; virtual conference).
Role:
Speaker
Year:
2021
Name:
PEGS Europe: Protein and Antibody Engineering Summit, Barcelona, Spain (session chair).
Role:
Speaker
Year:
2021
Name:
Festival of Biologics European Antibody Congress 2021, Basel, Switzerland (invited speaker).
Role:
Speaker
Year:
2021
Name:
Department of Pharmaceutical Science, SUNY Buffalo, Buffalo, NY (invited seminar; virtual presentation).
Role:
Speaker
Year:
2021
Name:
VIB Conference (‘Translational Immunology’), Ghent, Belgium (invited speaker).
Role:
Speaker
Year:
2021
Name:
Antibody Engineering and Therapeutics conference, San Diego, CA (session chair).
Role:
Speaker
Year:
2021
Name:
Gordon Research Conference, ‘Antibody Biology and Engineering’, Ventura, CA
Role:
Speaker
Year:
2022
Name:
Department of Immunology, Hokkaido University Faculty of Medicine, Sapporo, Japan.
Role:
Speaker
Year:
2023
Name:
Festival of Biologics USA, San Diego, CA.
Role:
Speaker
Year:
2023
Name:
Antibody Engineering and Therapeutics Europe, Amsterdam, Netherlands.
Role:
Speaker
Year:
2023
Name:
World Congress in Pharmacology, Glasgow, UK.
Role:
Speaker
Year:
2023
Name:
Amsterdam Immunogenicity and Tolerance Seminar, Amsterdam, Netherlands
Role:
Speaker
Year:
2023
Name:
Antibody Engineering and Therapeutics conference, San Diego, CA.
Role:
Speaker
Year:
2023
Name:
Keystone meeting, ‘Antibodies as Drugs: The Art in Antibody Engineering’, Breckenridge, CO.
Role:
Speaker
Year:
2024
Name:
FASEB Science Research Conference, ‘Immunoreceptors and Immunotherapy’, Minneapolis-St. Paul, MN.
Role:
Speaker
Year:
2024
Name:
From the Laboratory to the Clinic: 25 Years of Biological Therapy’, Oxford, UK.
Role:
Speaker
Year:
2024
Name:
Keystone meeting, ‘Antibodies as Drugs: Innovative Formats, Design and Engineering’, Keystone, CO.
Role:
Speaker
Year:
2025
Name:
Sydney Antibody Therapeutics 2025, Sydney, Australia (Keynote address).
Role:
Speaker
Year:
2025
Biography
Prizes
- Royal Society Wolfson Research Merit Award. (2018)
- Royal Society Wolfson Research Merit Award. (2019)
- Royal Society Wolfson Research Merit Award. (2020)
- Royal Society Wolfson Research Merit Award. (2018)
- Royal Society Wolfson Research Merit Award. (2019)
- Royal Society Wolfson Research Merit Award. (2020)
- Fellow of the Royal Society (2022)
- Established Investigator Award (1997)
- International Society of Molecular Recognition Award in Affinity Technology (2025)